A new clinical trial at Sanford Health is exploring how genetic changes that occur during breast cancer might help health care providers better identify, treat and control the disease. The clinical trial is called ELSA, which stands for “Evaluating Targets in Locally Advanced Breast Cancer by Sequencing Tumor DNA at Diagnosis and After Progression”.
Are you up for a challenge?
